Patrick Wood
Stock Analyst at Morgan Stanley
(2.86)
# 1,550
Out of 4,910 analysts
97
Total ratings
40.54%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $71 → $68 | $58.64 | +15.96% | 3 | Jul 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Equal-Weight | $75 → $81 | $75.80 | +6.86% | 9 | Jul 15, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $82 → $89 | $86.74 | +2.61% | 8 | Jul 15, 2025 | |
| BAX Baxter International | Maintains: Underweight | $28 → $27 | $28.77 | -6.15% | 5 | Jul 15, 2025 | |
| ALC Alcon | Maintains: Equal-Weight | $90 → $84 | $91.90 | -8.60% | 4 | Jul 15, 2025 | |
| RXST RxSight | Downgrades: Equal-Weight | $20 → $9 | $7.94 | +13.35% | 2 | Jul 15, 2025 | |
| SOLV Solventum | Upgrades: Overweight | $80 → $103 | $73.93 | +39.32% | 5 | Jul 15, 2025 | |
| STE STERIS | Upgrades: Overweight | $260 → $276 | $227.25 | +21.45% | 5 | Jul 15, 2025 | |
| BSX Boston Scientific | Maintains: Overweight | $120 → $125 | $106.21 | +17.69% | 6 | May 16, 2025 | |
| GKOS Glaukos | Maintains: Underweight | $110 → $72 | $94.38 | -23.71% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $86 → $78 | $76.77 | +1.60% | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $196 | $183.63 | +6.74% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $12 | $13.97 | -14.10% | 7 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $116.20 | +48.88% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $22 | $15.44 | +42.49% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $102 | $73.80 | +38.21% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $286.58 | +10.61% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $13.19 | -24.18% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $145 | $106.79 | +35.78% | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $18.99 | +94.84% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $144.77 | - | 5 | Dec 11, 2017 |
PROCEPT BioRobotics
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $58.64
Upside: +15.96%
Edwards Lifesciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $75.80
Upside: +6.86%
DexCom
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $82 → $89
Current: $86.74
Upside: +2.61%
Baxter International
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $28.77
Upside: -6.15%
Alcon
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $90 → $84
Current: $91.90
Upside: -8.60%
RxSight
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $7.94
Upside: +13.35%
Solventum
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $73.93
Upside: +39.32%
STERIS
Jul 15, 2025
Upgrades: Overweight
Price Target: $260 → $276
Current: $227.25
Upside: +21.45%
Boston Scientific
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $106.21
Upside: +17.69%
Glaukos
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $94.38
Upside: -23.71%
May 6, 2025
Maintains: Equal-Weight
Price Target: $86 → $78
Current: $76.77
Upside: +1.60%
May 6, 2025
Maintains: Overweight
Price Target: $280 → $196
Current: $183.63
Upside: +6.74%
May 6, 2025
Maintains: Equal-Weight
Price Target: $18 → $12
Current: $13.97
Upside: -14.10%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $116.20
Upside: +48.88%
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $15.44
Upside: +42.49%
Dec 6, 2024
Maintains: Equal-Weight
Price Target: $104 → $102
Current: $73.80
Upside: +38.21%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $286.58
Upside: +10.61%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $13.19
Upside: -24.18%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $104 → $145
Current: $106.79
Upside: +35.78%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $18.99
Upside: +94.84%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $144.77
Upside: -